ICUI ICU Medical, Inc. logo

ICUI ICU Medical, Inc.

Healthcare
$133.31+1.52%ClosedMarket Cap: $3.33B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

4239.18

PEG

42.13

P/B

1.56

P/S

1.54

EV/EBITDA

13.94

DCF Value

$-5.27

FCF Yield

2.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

36.4%

Operating Margin

3.7%

Net Margin

2.1%

ROE

2.2%

ROA

1.2%

ROIC

2.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$530.4M$30.1M$
Q4 null$540.3M$-15.7M$
FY null$2.23B$732.0K$
Q3 null$537.0M$-3.4M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$163.50

Target (Median)

$163.50

Target Range

$163.00 - $164.00

3 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
KeybancOverweight
2026-04-27
Piper SandlerOverweight
2026-04-17
KeybancOverweight
2026-02-20
Piper SandlerOverweight
2026-02-20
KeybancOverweight
2025-11-07

Trading Activity

Insider Trades

View All
Woolson Danielofficer: President
SellFri May 22
Sanzone Virginia Ruthofficer: VP, General Counsel
SellFri May 15
KENNEDY KOLLEEN Tdirector
SellWed May 13
KENNEDY KOLLEEN Tdirector
SellWed May 13
Hernandez Lauriedirector
SellWed May 13

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

0.74

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Peers